Head-to-Head Study Comparing TYRABRI To Copaxone And Rebif
March 26, 2010 Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) today announced enrollment of the first patient…
A study, much needed for determining long term usage of Tysabri®
IN Stuart’s own words, “I believe the purpose of this study is to see if stopping the use of Tysabri…
Stuart Schlossman
The Tysabri® “RESTORE” Study — an Interruption study of medication usage
FOR THOSE in FLORIDA, this study is taking place at Neurological Associates Research. – See information found below on How…
Stuart Schlossman
Sub Q – Tysabri Injection Study – for People With MS
The information found here was obtained from Erin T. A study to evaluate delivery of Natalizumab (Tysabri®) Study Rationale: While…
Stuart Schlossman
THE Multiple Sclerosis Resource Centre (MSRC) Tysabri Diaries
Did you know that if you are a Tysabri® user, you can have your own place to write diary or…
Stuart Schlossman
NFL Player will not let MS slow him down
By Kevin Scarbinsky — The Birmingham News February 28, 2010, Like a lot of football players, Courtney Taylor is waiting…
Stuart Schlossman
Tysabri Will Remain Decision Resources’ Clinical Gold Standard Through 2018 for the Treatment of Secondary Progressive Multiple Sclerosis
Biogen Idec/Elan’s Tysabri Will Remain Decision Resources’ Clinical Gold Standard Through 2018 for the Treatment of Secondary Progressive Multiple Sclerosis…
Stuart Schlossman
An MS patients’ views of his current Drug therapy for Multiple Sclerosis and about Quality of Life
Written By Stuart Schlossman – February 22, 2010 Albeit, I was not confident in having to make the decision to…
Stuart Schlossman
Tysabri now linked to (35) cases of PML – progressive multifocal leukoencephalopathy
Source: Bloomberg Report Biogen, Elan’s Drug Linked to 35 Brain-Disease Cases (Adds TYSABRI label information in the fifth paragraph, sales…
Stuart Schlossman
Tysabri (Natalizumab): Update of Healthcare Professional Information – “IRIS”
source: FDA.gov Audience: Neurological healthcare professionals, patients [Posted 02/05/2010] FDA notified healthcare professionals and patients that the risk of developing…
Stuart Schlossman
